Ball Bryan's Form 4 filing
Whitehawk Therapeutics, Inc. (WHWK) · filed Apr 13, 2026
- Accession no.
- 0001766522-26-000009
- Filed
- Apr 13, 2026
- Trade date
- Apr 9-10, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $201.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ball BryanCIK 0001766522 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | Common Stock | SSaleDisposed | −50,000 | $3.57 | −$178,500 | 522,551 | Direct | |
| Apr 10, 2026 | Common Stock | SSaleDisposed | −6,596 | $3.43 | −$22,624.28 | 515,955 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Chief Technical Operations Officer and SVP, Manufacturing Operations